NCT01770743: A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels |
|
|
| Completed | 2 | 168 | US | AV7909, AV7909 Anthrax Vaccine, NuThrax, BioThrax, Anthrax Vaccine Adsorbed (AVA) | Emergent BioSolutions, National Institute of Allergy and Infectious Diseases (NIAID) | Anthrax | 02/14 | 12/14 | | |
